A Study of Amphotericin B Liposome for Injection in Patients With Persistent Neutropenia and Fever
Status:
Not yet recruiting
Trial end date:
2023-01-15
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, single-arm, phase III study to evaluate the safety and
efficacy of Amphotericin B liposomes in patients with persistent neutropenia and fever.